Lynch DR - Search Results

1

Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction.

Dorsch MP, Lee JS, Lynch DR, Dunn SP, Rodgers JE, Schwartz T, Colby E, Montague D, Smyth SS. Dorsch MP, et al. Among authors: lynch dr. Ann Pharmacother. 2007 May;41(5):737-41. doi: 10.1345/aph.1H621. Epub 2007 Apr 24. Ann Pharmacother. 2007. PMID: 17456544

2

Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.

Williams MS, Weiss EJ, Sabatine MS, Simon DI, Bahou WF, Becker LC, Parise LV, Dauerman HL, French PA, Smyth SS, Becker RC; 2010 Platelet Colloquium Participants. Williams MS, et al. Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2372-84. doi: 10.1161/ATVBAHA.110.218131. Arterioscler Thromb Vasc Biol. 2010. PMID: 21084706 Free PMC article. Review.

3

Changes in thromboinflammatory profiles across the generations of transcatheter aortic heart valves.

Sexton T, Alkhasova M, de Beer M, Lynch D, Smyth S. Sexton T, et al. J Thromb Thrombolysis. 2019 Feb;47(2):174-178. doi: 10.1007/s11239-018-1782-3. J Thromb Thrombolysis. 2019. PMID: 30484011 Free PMC article.

4

Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses.

Rowley JW, Finn AV, French PA, Jennings LK, Bluestein D, Gross PL, Freedman JE, Steinhubl SR, Zimmerman GA, Becker RC, Dauerman HL, Smyth SS; 2011 Platelet Colloquium Participants. Rowley JW, et al. Circ Cardiovasc Interv. 2012 Apr;5(2):296-304. doi: 10.1161/CIRCINTERVENTIONS.111.965426. Circ Cardiovasc Interv. 2012. PMID: 22511738 Free PMC article. Review. No abstract available.

5

Recurrent myocardial infarction associated with gefitinib therapy.

Lynch DR Jr, Kickler TS, Rade JJ. Lynch DR Jr, et al. J Thromb Thrombolysis. 2011 Jul;32(1):120-4. doi: 10.1007/s11239-010-0539-4. J Thromb Thrombolysis. 2011. PMID: 21184253

6

Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia.

Serebruany VL, Miller M, Pokov AN, Lynch D, Jensen JK, Hallén J, Atar D. Serebruany VL, et al. Cardiology. 2011;118(3):187-94. doi: 10.1159/000329300. Epub 2011 Jun 22. Cardiology. 2011. PMID: 21701167 Clinical Trial.

7

Persistent high on-treatment platelet reactivity in acute coronary syndrome.

Lynch DR Jr, Khan FH, Vaidya D, Williams MS. Lynch DR Jr, et al. J Thromb Thrombolysis. 2012 Apr;33(3):267-73. doi: 10.1007/s11239-012-0678-x. J Thromb Thrombolysis. 2012. PMID: 22362558

8

Characterization of clinical serum cardiac biomarker levels in individuals with Friedreich ataxia.

Lynch DR, Sharma S, Hearle P, Greeley N, Gunther K, Keita M, Strawser C, Hauser L, Park C, Schadt K, Lin KY. Lynch DR, et al. J Neurol Sci. 2024 May 14;461:123053. doi: 10.1016/j.jns.2024.123053. Online ahead of print. J Neurol Sci. 2024. PMID: 38759249

9

Friedreich Ataxia Caregiver-Reported Health Index: Development of a Novel, Disease-Specific Caregiver-Reported Outcome Measure.

Seabury J, Varma A, Weinstein J, Rosero SJ, Engebrecht C, Khosa S, Zizzi C, Wagner ES, Alexandrou D, Cohen BL, Dilek N, Heatwole JM, Lynch DR, Park CC, Wells M, Subramony SH, Heatwole CR. Seabury J, et al. Among authors: lynch dr. Neurol Clin Pract. 2024 Jun;14(3):e200303. doi: 10.1212/CPJ.0000000000200300. Epub 2024 May 10. Neurol Clin Pract. 2024. PMID: 38751829

10

Pharmacotherapeutic strategies for Friedreich Ataxia: a review of the available data.

Gunther K, Lynch DR. Gunther K, et al. Among authors: lynch dr. Expert Opin Pharmacother. 2024 Apr 18:1-11. doi: 10.1080/14656566.2024.2343782. Online ahead of print. Expert Opin Pharmacother. 2024. PMID: 38622054 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

300 results

Search Page